Clinical Trial

An Open-Label PET/CT Imaging Study to Evaluate Brain Serotonin Transporter (SERT) Occupancy Following Single-Dose Administration of LG-0317 Tablets in Healthy Participants

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of the study is to evaluate brain serotonin transporter (SERT) receptor occupancy (RO) following single oral doses of LG-0317 tablets in healthy male participants; and to explore the pharmacokinetic/pharmacodynamic (PK/PD) relationship between LG-0317 plasma concentrations and SERT occupancy..
Trial Details
NCT Number NCT07708428
Lead Sponsor LinGang Laboratory
Conditions Healthy Volunteers (HV)
Enrollment 12 participants
Start Date 2026-07-24
Primary Completion 2026-09-30 (estimated)
Study Completion 2027-02-02 (estimated)
Updated on ClinicalTrials.gov 2026-07-16